Core Insights - Universal Health Services (UHS) reported revenue of $4.1 billion for the quarter ended March 2025, reflecting a year-over-year increase of 6.7% [1] - Earnings per share (EPS) for the quarter was $4.84, up from $3.70 in the same quarter last year, resulting in an EPS surprise of +11.01% against the consensus estimate of $4.36 [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $4.14 billion, showing a surprise of -1.06% [1] Financial Performance Metrics - Behavioral health admissions totaled 117,788, which was below the two-analyst average estimate of 122,821 [4] - Net revenues from behavioral health services were reported at $1.75 billion, compared to the average estimate of $1.79 billion, marking a year-over-year increase of +5.5% [4] - Net revenues from acute care hospital services matched the average estimate of $2.35 billion, representing a +7.5% change from the previous year [4] - Operating income for behavioral health care services was $337.68 million, slightly below the three-analyst average estimate of $346.29 million [4] - Operating income for acute care hospital services was reported at $254.79 million, exceeding the average estimate of $206.21 million [4] Stock Performance - Shares of Universal Health Services have returned -7.8% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [3]

In its upcoming report, Tenet Healthcare (THC) is predicted by Wall Street analysts to post quarterly earnings of $3.11 per share, reflecting a decline of 3.4% compared to the same period last year. Revenues are forecasted to be $5.14 billion, representing a year-over-year decrease of 4.3%. Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their init ...

华为与中山七院共建"鲲鹏+昇腾"自主创新平台，将实现医院业务系统、数据库及ICT基础设施的智能 化。创新中心通过AI驱动影像质控优化、远程智能诊疗探索、智慧化病区管理升级及AI辅助临床决策 优化，打造覆盖诊疗全流程的智能化解决方案。 中山七院院长何裕隆强调，智慧医院是公立医院高质量发展的必由之路，此次合作是院企技术整合的典 范，期待通过共建创新中心，实现"优质资源全域共享"。 深圳商报•读创客户端记者 陈姝 4月23日，中山大学附属第七医院（以下简称"中山七院"）与华为技术有限公司（下文简称"华为"）签 署全面合作协议，并与联影医疗技术集团有限公司、深圳市联新移动医疗科技有限公司（以下简称"联 影""联新"）在深圳共同签署三方合作协议，合作共建"中山大学附属第七医院智慧医疗联合创新中 心"（以下简称"创新中心"）。 揭牌仪式（活动主办方供图） 创新中心将采用即将建成的10.0P级医疗人工智能算力中心，通过产学研医深度融合，推动智慧医疗自 主创新，促进医院高质量发展，助力国家实施"健康中国"战略。 在揭牌仪式上，中山七院副院长魏富鑫表示，此次的合作亮点是通过技术赋能，破解临床痛点。此次合 作以打造"三位一体"智 ...

Core Viewpoint - HCA Healthcare, Inc. reported strong first-quarter 2025 results with adjusted earnings per share (EPS) of $6.45, exceeding estimates and showing a year-over-year increase of 20.3% [1]. Financial Performance - Revenues for the first quarter reached $18.3 billion, reflecting a 5.7% year-over-year growth and slightly surpassing consensus estimates by 0.1% [1]. - Adjusted EBITDA increased to $3.7 billion from $3.4 billion in the previous year [4]. Operational Metrics - Same-facility equivalent admissions rose by 2.6% year over year, while same-facility admissions increased by 2.8%, both falling short of growth estimates [3]. - Same-facility revenue per equivalent admission grew by 2.9% year over year, missing the growth estimate of 3% [3]. - Same-facility inpatient surgeries saw a minor increase of 0.2% year over year, below the expected 2.2% growth, while outpatient surgeries decreased by 2.1% [4]. - Emergency room visits increased by 4% year over year [4]. Expense Overview - Salaries and benefits, supplies, and other operating expenses rose by 4.4% year over year to $14.6 billion, which was lower than the estimated $14.8 billion [4]. Cash Flow and Capital Deployment - Cash generated from operations was $1.7 billion, down from $2.5 billion in the previous year [8]. - The company repurchased shares worth $2.5 billion in the first quarter, with an available buyback capacity of $8.3 billion [9]. Financial Position - As of March 31, 2025, HCA Healthcare had cash and cash equivalents of $1 billion, down from $1.9 billion at the end of 2024 [6]. - Total assets increased to $59.8 billion from $59.5 billion at the end of 2024, while long-term debt rose to $41.1 billion from $38.3 billion [6]. Guidance - HCA Healthcare anticipates annual revenues between $72.8 billion and $75.8 billion for 2025, indicating a 5.2% rise from 2024 [10]. - Adjusted EBITDA is expected to range from $14.3 billion to $15.1 billion, reflecting a 5.9% growth from the previous year [10]. - EPS is forecasted to be between $24.05 and $25.85, implying a 13.6% increase from 2024 [11].

OCI delivers improved performance and scalability to help increase efficiency and innovation  AUSTIN, Texas, April 25, 2025 /PRNewswire/ -- North York General Hospital (NYGH) in Toronto, Canada, has improved the performance and usability of its Oracle Health Foundation electronic health record (EHR) by migrating it to Oracle Cloud Infrastructure (OCI). With OCI, NYGH is able to offer a better experience for its patients and providers and enable a more agile approach to adopting new technologies like generat ...

Core Viewpoint - Amedisys, Inc. reported strong financial results for the first quarter of 2025, highlighting significant growth in net service revenue and net income, alongside the context of a pending merger with UnitedHealth Group [1][3][6]. Financial Performance - Net service revenue increased by $23.4 million to $594.8 million compared to $571.4 million in the same period of 2024 [6]. - Net income attributable to Amedisys, Inc. was $61.0 million, which included merger-related expenses of $16.8 million and a gain of $48.1 million on an equity method investment [6][12]. - Adjusted EBITDA for the quarter was $68.8 million, up from $59.9 million in 2024 [6][19]. - Adjusted net income attributable to Amedisys, Inc. was $41.6 million, compared to $33.9 million in 2024 [6][20]. Earnings Per Share - Net income attributable to Amedisys, Inc. per diluted share was $1.84, a significant increase from $0.44 in 2024 [6][21]. - Adjusted net income attributable to Amedisys, Inc. per diluted share was $1.25, compared to $1.03 in the previous year [6][21]. Operational Highlights - The company operates approximately 519 care centers across 38 states and the District of Columbia, serving over 499,000 patients annually [5]. - Amedisys has partnerships with more than 3,300 hospitals and 114,000 physicians nationwide [5]. Merger Context - The company will not conduct a quarterly earnings call due to the pending merger with UnitedHealth Group, indicating a strategic focus on the merger process [3][6].

Healthcare Services Group, Inc. (NASDAQ:HCSG) Q1 2025 Results Conference Call April 23, 2025 8:30 AM ET Company Participants Ted Wahl - President and Chief Executive Officer Matt McKee - Chief Communication Officer Vikas Singh - Chief Financial Officer Conference Call Participants Andy Wittmann - Baird A.J. Rice - UBS Tao Qiu - Macquarie Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Health ...

Healthcare Services Group (HCSG) Q1 2025 Earnings Call April 23, 2025 08:30 AM ET Company Participants Theodore Wahl - President, Chief Executive OfficerMatthew McKee - Chief Communications OfficerVikas Singh - EVP & CFOA.J. Rice - Managing Director Conference Call Participants Andrew Wittmann - Senior Research AnalystTao Qiu - Equity Research Analyst Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone ...

Healthcare Services Group (HCSG) Q1 2025 Earnings Call April 23, 2025 08:30 AM ET Company Participants Theodore Wahl - President, Chief Executive OfficerMatthew McKee - Chief Communications OfficerVikas Singh - EVP & CFOA.J. Rice - Managing Director Conference Call Participants Andrew Wittmann - Senior Research AnalystTao Qiu - Equity Research Analyst Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone ...

Core Viewpoint - Evolent Health, Inc. has nominated Mr. Shawn Guertin for election to its Board of Directors, reflecting the company's ongoing efforts to refresh its board and enhance corporate governance practices [1][2][3] Company Overview - Evolent Health specializes in improving health outcomes for individuals with complex conditions through innovative solutions that simplify and reduce the cost of healthcare [7] - The company serves a national base of leading payers and providers and is recognized as a top workplace in the healthcare sector [7] Board of Directors - Mr. Shawn Guertin, with nearly 40 years of experience in the insurance and healthcare sectors, has been recommended for election to the Board [2] - His previous roles include Executive Vice President and Chief Financial Officer at CVS Health Corporation and various leadership positions at Aetna and Coventry Health Care [6] - If elected, Mr. Guertin will replace Diane Holder, who has served on the board for 14 years and is not seeking re-election [4][5] Board Refreshment - Mr. Guertin's nomination marks the sixth new independent director added to the Board in the past four years, indicating a commitment to aligning corporate governance with best practices [3][8] - The Board's Nominating and Governance Committee conducted a search process to identify suitable candidates for the independent director position [2]